GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allied Healthcare Products Inc (OTCPK:AHPIQ) » Definitions » Cash Flow from Operations

Allied Healthcare Products (Allied Healthcare Products) Cash Flow from Operations : $-4.10 Mil (TTM As of Jun. 2022)


View and export this data going back to 1992. Start your Free Trial

What is Allied Healthcare Products Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Jun. 2022, Allied Healthcare Products's Net Income From Continuing Operations was $-1.94 Mil. Its Depreciation, Depletion and Amortization was $0.11 Mil. Its Change In Working Capital was $-1.41 Mil. Its cash flow from deferred tax was $0.00 Mil. Its Cash from Discontinued Operating Activities was $0.00 Mil. Its Asset Impairment Charge was $0.00 Mil. Its Stock Based Compensation was $0.00 Mil. And its Cash Flow from Others was $0.58 Mil. In all, Allied Healthcare Products's Cash Flow from Operations for the three months ended in Jun. 2022 was $-2.66 Mil.


Allied Healthcare Products Cash Flow from Operations Historical Data

The historical data trend for Allied Healthcare Products's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Healthcare Products Cash Flow from Operations Chart

Allied Healthcare Products Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.86 0.06 0.65 -3.78 -4.10

Allied Healthcare Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 -0.69 -1.14 0.39 -2.66

Allied Healthcare Products Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Allied Healthcare Products's Cash Flow from Operations for the fiscal year that ended in Jun. 2022 is calculated as:

Allied Healthcare Products's Cash Flow from Operations for the quarter that ended in Jun. 2022 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allied Healthcare Products  (OTCPK:AHPIQ) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Allied Healthcare Products's net income from continuing operations for the three months ended in Jun. 2022 was $-1.94 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Allied Healthcare Products's depreciation, depletion and amortization for the three months ended in Jun. 2022 was $0.11 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Allied Healthcare Products's change in working capital for the three months ended in Jun. 2022 was $-1.41 Mil. It means Allied Healthcare Products's working capital declined by $1.41 Mil from Mar. 2022 to Jun. 2022 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Allied Healthcare Products's cash flow from deferred tax for the three months ended in Jun. 2022 was $0.00 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Allied Healthcare Products's cash from discontinued operating Activities for the three months ended in Jun. 2022 was $0.00 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Allied Healthcare Products's asset impairment charge for the three months ended in Jun. 2022 was $0.00 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Allied Healthcare Products's stock based compensation for the three months ended in Jun. 2022 was $0.00 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Allied Healthcare Products's cash flow from others for the three months ended in Jun. 2022 was $0.58 Mil.


Allied Healthcare Products Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Allied Healthcare Products's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Healthcare Products (Allied Healthcare Products) Business Description

Traded in Other Exchanges
N/A
Address
1720 Sublette Avenue, Saint Louis, MO, USA, 63110
Allied Healthcare Products Inc manufactures a variety of respiratory products used in the healthcare industry in a wide range of hospital and alternate site settings, including sub-acute care facilities, home health care, and emergency medical care. The product line of the company includes respiratory anesthesia products, home respiratory care products, medical gas system construction products, medical gas system regulation devices, disposable oxygen, and specialty gas cylinders, portable suction equipment, trauma, and patient handling products, respiratory products, and others. The company markets its products under various brand names Timeter, Carbolime, Litholyme, Schuco, Chemetron, Oxequip, Lif-O-Gen, Gomco, and others.
Executives
John D Weil director, 10 percent owner 10 S. BROADWAY, SUITE 2000, ST LOUIS MO 63102
Susan M Deuser director 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Kevin D Kroupa officer: Vice President of Operations 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Earl R Refsland director, officer: President and CEO 1720 SUBLETT AVENUE, ST. LOUIS MO 63110
Joseph F Ondrus officer: Vice President of Operations 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Andrew Riley officer: VP of Operations 1720 SUBLETTE AVE., ST. LOUIS MO 63110
William A Peck director 35 CROSBY DRIVE, BEDFORD MA 01730
Daniel C Dunn officer: VP - Finance and CFO 1720 SUBLETTE AVE, ST. LOUIS MO 63110
Eldon P Rosentrater officer: VP - Administration 1720 SUBLETTE AVE, ST. LOUIS MO 63110
Root Joseph Ernest Jr director HAYNES BEFFEL & WOLFELD LLP, 751 KELLY STREET, HALF MOON BAY CA 94019
Robert Bradley Harris officer: Vice President of Operations 15 RIVER RIDGE TRAIL, ORMOND BEACH FL 32174
Judy T Graves director 13317 WESTERMAN RD, ST LOUIS MO 63122
Hickey James B Jr director 4608 EDINA BLVD, EDINA MN 55424
Richard A Setzer officer: VICE PRESIDENT SALES & MKTG 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Brent D Baird director 1350 ONE M&T PLAZA, BUFFALO NY 14203-2396